Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,604 public trials 547 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma

NCT02406144

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Complejo Hospitalario Universitario de Santiago A Coruña, Spain
  • Hospital Txagorritxu Alava, Spain
  • Hospital General de Albacete Albacete, Spain
  • Hospital Del Vinalopo Alicante, Spain
View all 74 locations
View Trial Details
Completed

Sequential High-dose Dexamethasone and Response Adopted PAD or VAD Induction Chemotherapy Followed by High-dose Chemotherapy With Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma

NCT01255514

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • National Cancer Center Goyang, South Korea
  • Chonnam National University Hwasun Hospital Hwasun, South Korea
  • Gachon University Gill Hospital Incheon, South Korea
  • Severance Hospital Seoul, South Korea
View Trial Details
Completed

Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies

NCT00629473

Conditions
Advanced Cancer, Blood Protein Disorders, Cardiovascular Diseases, +21 more
Locations
  • Mater Adult Hospital South Brisbane, Queensland, Australia
  • The Queen Elizabeth Hospital Woodville South, South Australia, Australia
  • Peter MacCallum Cancen Center Melbourne, Victoria, Australia
  • The Alfred Hospital Melbourne, Victoria, Australia
View Trial Details
Completed

NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma

NCT00667082

Conditions
Blood Protein Disorders, Bronchial Neoplasms, Carcinoma, Bronchogenic, +40 more
Locations
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • The Queen Elizabeth Hospital Woodville South, South Australia, Australia
  • Sir Charles Gairdner Hospital and University of Western Australia Nedlands, Western Australia, Australia
View Trial Details
Completed

A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers

NCT01524978

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Arizona Oncology Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers, LLP Aurora, Colorado, United States
  • Massachusetts General Hospital;Oncology Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 34 locations
View Trial Details

Related conditions